T1	Person 0 3	Age
T2	Value 4 21	18 years or older
R1	Has_value Arg1:T1 Arg2:T2	
T3	Qualifier 38 50	asymptomatic
T4	Condition 51 74	coronary artery disease
T5	Qualifier 23 34	Symptomatic
*	OR T3 T5
T6	Scope 23 50	Symptomatic or asymptomatic
R2	Has_scope Arg1:T4 Arg2:T6	
T7	Measurement 85 88	MLA
T8	Measurement 89 109	minimal luminal area
R3	Subsumes Arg1:T7 Arg2:T8	
T9	Value 110 115	<4mm2
R4	Has_value Arg1:T7 Arg2:T9	
T10	Measurement 117 130	plaque burden
T11	Value 130 134	>70%
T12	Condition 136 153	Lipid-rich plaque
T13	Procedure 157 161	NIRS
T14	Procedure 162 202	Intracoronary Near-Infrared Spectroscopy
R5	Subsumes Arg1:T13 Arg2:T14	
R6	AND Arg1:T13 Arg2:T12	
T15	Measurement 216 226	maxLCBI4mm
T16	Value 226 230	>315
R7	Has_value Arg1:T15 Arg2:T16	
R8	Subsumes Arg1:T12 Arg2:T15	
T17	Multiplier 233 234	2
T18	Condition 235 260	target vulnerable lesions
R9	Has_multiplier Arg1:T18 Arg2:T17	
T19	Mood 262 274	Eligible for
T20	Procedure 275 309	percutaneous coronary intervention
T21	Device 315 353	Absorb Bioresorbable Vascular Scaffold
T22	Device 357 381	Everolimus Eluting Stent
*	OR T21 T22
T23	Scope 315 381	Absorb Bioresorbable Vascular Scaffold or Everolimus Eluting Stent
R10	Has_mood Arg1:T20 Arg2:T19	
R11	Has_scope Arg1:T20 Arg2:T23	
T24	Post-eligibility 383 435	Willing and able to provide informed written consent
T25	Measurement 437 462	Reference vessel diameter
T26	Value 463 471	2.75-4.0
R12	Has_value Arg1:T25 Arg2:T26	
T27	Measurement 473 486	Lesion length
T28	Value 487 491	= 40
R13	Has_value Arg1:T27 Arg2:T28	
